STAT3 and neoplasm: Inhibiting the IL-6/STAT3 signaling pathway correspondingly shifts macrophages to the M1 polarization phenotype, and blocking the IL-6/STAT3 signaling pathway can dramatically reduce tumor formation (Yin et al., 2018).